Sponsor Pipeline

Bai-Rong Xia Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07667751 An Exploratory Study on the Use of Ipalotinib (Tislelizumab) Combined With Sunitinib and… Ovary Cancer Recruiting
NCT07125391 Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced… Ovarian Cancer Recruiting
NCT05652283 Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian… Ovarian Cancer Active, Not Recruiting
Disease Areas
Ovarian Cancer (2)
Get alerts when Bai-Rong Xia's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free